May 26 (Reuters) - AstraZeneca has signed a manufacturing agreement for its COVID-19 vaccine with Nipro Corp for supply in Japan, the Tokyo-listed firm said on Wednesday, adding that the contract was for filling the shot into vials and packaging it. (Reporting by Pushkala Aripaka in Bengaluru; Editing by Arun Koyyur)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,264 GBX | +1.20% | +0.77% | +15.70% |
08:12pm | AstraZeneca, Merck Sue Over Alleged Cancer Drug Patents Infringement | MT |
07:56pm | AstraZeneca, Merck Sue Over Cancer Drug Patent Infringement | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.70% | 236B | |
+33.33% | 700B | |
-4.84% | 358B | |
+18.83% | 330B | |
+3.36% | 287B | |
+6.68% | 202B | |
-9.08% | 197B | |
+5.86% | 161B | |
-2.01% | 157B | |
+3.70% | 124B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca : Nipro sign COVID-19 vaccine deal for supply in Japan